A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and steroid-sensitive nephrotic syndrome in children
Restricted accessResearch articleFirst published online March, 2012
A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and steroid-sensitive nephrotic syndrome in children
Background and objective: Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism correlates with circulating and cellular ACE concentration. Association between ACE I/D gene polymorphism and steroid-sensitive nephrotic syndrome (SSNS) risk in children is still controversial. This meta-analysis was performed to evaluate the relation between ACE I/D gene polymorphism and SSNS susceptibility in children.
Methods: The relevant investigations were screened from the search engines of PubMed, Cochrane Library and CBM-disc (China Biological Medicine Database) as of 1 March 2011, and eligible studies were synthesized using meta-analysis methods.
Results: Ten studies were identified for the analysis of association between ACE I/D gene polymorphism and SSNS risk in children, including seven in Asians, one for Caucasians and two in Africans. There was no markedly positive association between D allele or DD genotype and SSNS susceptibility in Asians, Caucasians and Africans (D: Asians OR = 1.24, p = 0.28; Caucasians OR = 1.61, p = 0.15; Africans OR = 1.61, p = 0.53; DD: Asians OR = 1.72, p = 0.15; Caucasians OR = 1.39, p = 0.48; Africans OR = 1.80, p = 0.56). Furthermore, II homozygous seemed not to play a protective role against SSNS onset for Asians, Caucasians and Africans (Asians OR = 0.95, p = 0.85; Caucasians OR = 0.30, p = 0.11; Africans OR = 0.60, p = 0.65).
Conclusions: There was no association between ACE I/D gene polymorphism and SSNS susceptibility in Asians, Caucasians and Africans. However, the conclusions for Caucasians and Africans were less powerful.
KodnerC. Nephrotic syndrome in adults: diagnosis and management. Am Fam Physician2009; 80: 1129–1134.
2.
MadaniAIsfahaniSTRahimzadehN. Effect of levamisole in steroid-dependent nephrotic syndrome. Iran J Kidney Dis2010; 4: 292–296.
3.
TsaiIJYangYHLinYHWuVCTsauYKHsiehFJ. Angiotensin-converting enzyme gene polymorphism in children with idiopathic nephrotic syndrome. Am J Nephrol2006; 26: 157–162.
4.
ChangJWTsaiHLWangHHYangLY. Clinicopathological features and prognosis of Chinese children with idiopathic nephrotic syndrome between different age groups. Eur J Pediatr2009; 168: 1189–1194.
5.
SasseBHailemariamSWuthrichRPKemperMJNeuhausTJ. Angiotensin converting enzyme gene polymorphisms do not predict the course of idiopathic nephrotic syndrome in Swiss children. Nephrology (Carlton) 2006; 11: 538–541.
6.
SettinAElbazRAbbasAAbd-Al-SamadANoamanA. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction. J Renin Angiotensin Aldosterone Syst2009; 10: 96–100.
OktemFSirinABilgeIEmreSAgachanBIspirT. ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome. Pediatr Nephrol2004; 19: 384–389.
9.
Al-EisaAHaiderMZSrivastvaBS. Angiotensin converting enzyme gene insertion/deletion polymorphism in idiopathic nephrotic syndrome in Kuwaiti Arab children. Scand J Urol Nephrol2001; 35: 239–242.
10.
PatilSJGulatiSKhanFTripathiMAhmedMAgrawalS. Angiotensin converting enzyme gene polymorphism in Indian children with steroid sensitive nephrotic syndrome. Indian J Med Sci2005; 59: 431–435.
11.
DangXQYiZWHeXJ. Angiotensin I-converting enzyme gene polymorphism in children with nephrotic syndrome. Chin J Pediatr2000; 38: 288–291.
12.
Saber-AyadMSabrySAbdel-LatifINabilHEl-AzmSAAbdel-ShafyS. Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism on steroid resistance in Egyptian children with idiopathic nephrotic syndrome. J Renin Angiotensin Aldosterone Syst2010; 11: 111–118.
13.
FahmyMEFattouhAMHegazyRAEssawiML. ACE gene polymorphism in Egyptian children with idiopathic nephrotic syndrome. Bratisl Lek Listy2008; 109: 298–301.
14.
CelikUSNoyanABayazitAK. ACE gene polymorphism in Turkish children with nephrotic syndrome. Ren Fail2006; 28: 401–403.
15.
YangFLiuWJLiuPP. Study on gene polymorphism of renin angiotensin system in children with nephritic syndrome. Journal of Jinan University (Medicine Edition)2005; 26: 246–251.
16.
GeorgeGPMittalRD. Genetic polymorphisms in MHC-encoded antigen processing gene TAP2: A case–control study in end-stage renal disease patients of north India. Transpl Immunol2011: 220–223.
17.
LeeJPYangSHKimDK. In-vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy. Am J Physiol Renal Physiol2011; 300: F1283–1290.
18.
O’SeaghdhaCMParekhRSHwangSJ. The MYH9/APOL1 region and chronic kidney disease in European–Americans. Hum Mol Genet2011; 20: 2450–2456.
19.
BalakumarPJagadeeshG. Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin–angiotensin–aldosterone system. J Cardiovasc Pharmacol2010; 56: 570–579.
20.
MorishitaYHanawaSChindaJIimuraOTsunematsuSKusanoE. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension. Hypertens Res2011; 34: 308–313.
21.
YimHEKimJHYooKHBaeISHongYSLeeJW. Spironolactone and enalapril up-regulate differentially the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney. Pediatr Res2011; 69: 378–383.
ZhouTBQinYHSuLNLeiFYHuangWFZhaoYJ. ACE I/D gene polymorphism can’t predict the steroid responsiveness in Asian children with idiopathic nephrotic syndrome: a meta-analysis. PLoS One2011; 6: e19599.
24.
ArfaINouiraSAbidA. Lack of association between renin–angiotensin system (RAS) polymorphisms and hypertension in Tunisian type 2 diabetics. Tunis Med2010; 88: 38–41.
25.
QinYHZhouTBSuLNLeiFYHuangWFZhaoYJ. Association between ACE polymorphism and risk of IgA nephropathy: a meta-analysis. J Renin Angiotensin Aldosterone Syst2011; 12: 215–223.
26.
ZhouTBQinYHSuLN. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst2011; 00: 1–9.
27.
ZhouTBQinYHSuLNLeiFYHuangWFZhaoYJ. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and susceptibility of minimal change nephrotic syndrome: a meta-analysis. Int J Nephrol2011; 2011: 1–6.
28.
LambertDWClarkeNETurnerAJ. Not just angiotensinases: new roles for the angiotensin-converting enzymes. Cell Mol Life Sci2010; 67: 89.
29.
LubelJSHerathCBBurrellLMAngusPW. Liver disease and the renin–angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol2008; 23: 1327–1338.
30.
Ribeiro-OliveiraAJrNogueiraAIPereiraRMBoasWWDosSRSimoesESA. The renin–angiotensin system and diabetes: an update. Vasc Health Risk Manag2008; 4: 787–803.
31.
MoonJYTanimotoMGohdaT. Attenuating effect of angiotensin-(1–7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-Ay/Ta mice. Am J Physiol Renal Physiol2011; 300: F1271–F1282.
32.
LeeFTCaoZLongDMPanagiotopoulosSJerumsGCooperME. Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol2004; 15: 2139–2151.
33.
KangSJYouAKwakMK. Suppression of Nrf2 signaling by angiotensin II in murine renal epithelial cells. Arch Pharm Res2011; 34: 829–836.
34.
IdeuraHHiromuraKHiramatsuNShigeharaTTakeuchiSTomiokaM. Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. Am J Physiol Renal Physiol2007; 293: F1214–F1221.
35.
XiaoJLeungJCChanLYTangSCLaiKN. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. Clin Immunol2009; 132: 266–276.
